Healthcare Costs Among Patients with Heart Failure: A Comparison of Costs between Matched Decedent and Survivor Cohorts
ConclusionPatients with HF who died within 1 year after an index HF encounter incurred markedly higher costs within 1 year (despite the much shorter post-index period) and PPPM costs than those who survived, with the majority of costs attributable to hospitalizations for both patient cohorts. There may be opportunities for improving outcome s in HF, considering higher use of pharmacotherapy and lower costs were seen among survivors.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Drugs & Pharmacology | Healthcare Costs | Heart | Heart Failure | Medicare | Study